Skip to main content
. Author manuscript; available in PMC: 2013 Jul 13.
Published in final edited form as: Vaccine. 2012 May 28;30(33):4977–4982. doi: 10.1016/j.vaccine.2012.05.037

Figure 2.

Figure 2

MPF augments a suboptimal gentamicin regime. Mice (n=10) were infected with 50 CFU of Ft Schu S4 (i.n.) and gentamicin (10 mg/kg) was given starting 24 h post-infection. MPF (10 μg) or CLDC (100 μg/ml) was given i.p. on days 1 and 4 post-infection along with the gentamicin treatment. Untreated controls were given D5W i.p. in lieu of immunotherapy. Survival was monitored for 25 days. Data are representative of three independent experiments. Statistical significance was determined using a Mantel Cox log rank test. **p < 0.001.